Hainsworth J - Search Results

1

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.

Meric-Bernstam F, Hurwitz H, Raghav KPS, McWilliams RR, Fakih M, VanderWalde A, Swanton C, Kurzrock R, Burris H, Sweeney C, Bose R, Spigel DR, Beattie MS, Blotner S, Stone A, Schulze K, Cuchelkar V, Hainsworth J. Meric-Bernstam F, et al. Among authors: hainsworth j. Lancet Oncol. 2019 Apr;20(4):518-530. doi: 10.1016/S1470-2045(18)30904-5. Epub 2019 Mar 8. Lancet Oncol. 2019. PMID: 30857956 Free PMC article. Clinical Trial.

2

Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.

Johnson DH, Hainsworth JD, DeVore R, Hande KR, Greco FA. Johnson DH, et al. Among authors: hainsworth jd. Oncology. 1992;49 Suppl 1:57-61; discussion 61-2. doi: 10.1159/000227112. Oncology. 1992. PMID: 1323813 Clinical Trial.

3

Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.

Johnson DH, DeVore R, Greco FA, Walls J, Thomas M, Hande KR, Hainsworth JD. Johnson DH, et al. Among authors: hainsworth jd. Semin Oncol. 1992 Feb;19(1 Suppl 2):50-6. Semin Oncol. 1992. PMID: 1329223 Clinical Trial.

4

Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.

Greco FA, Johnson DH, Hainsworth JD. Greco FA, et al. Among authors: hainsworth jd. Semin Oncol. 1992 Dec;19(6 Suppl 13):14-8. Semin Oncol. 1992. PMID: 1492223

5

Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer.

Hainsworth JD, Andrews MB, Johnson DH, Greco FA. Hainsworth JD, et al. J Clin Oncol. 1991 Oct;9(10):1731-5. doi: 10.1200/JCO.1991.9.10.1731. J Clin Oncol. 1991. PMID: 1919624 Clinical Trial.

6

Combined small-cell and non-small-cell lung cancer.

Mangum MD, Greco FA, Hainsworth JD, Hande KR, Johnson DH. Mangum MD, et al. Among authors: hainsworth jd. J Clin Oncol. 1989 May;7(5):607-12. doi: 10.1200/JCO.1989.7.5.607. J Clin Oncol. 1989. PMID: 2540288

7

The management of patients with adenocarcinoma and poorly differentiated carcinoma of unknown primary site.

Greco FA, Hainsworth JD. Greco FA, et al. Among authors: hainsworth jd. Semin Oncol. 1989 Aug;16(4 Suppl 6):116-22. Semin Oncol. 1989. PMID: 2669133 Review.

8

Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.

Hesketh PJ, Beck T, Uhlenhopp M, Kris MG, Hainsworth JD, Harker WG, Cohen JR, Lester E, Kessler JF, Griffen D, et al. Hesketh PJ, et al. Among authors: hainsworth jd. J Clin Oncol. 1995 Aug;13(8):2117-22. doi: 10.1200/JCO.1995.13.8.2117. J Clin Oncol. 1995. PMID: 7636556 Clinical Trial.

9

Paclitaxel by 1-hour infusion in combination chemotherapy of stage III non-small cell lung cancer.

Greco FA, Stroup SL, Hainsworth JD. Greco FA, et al. Among authors: hainsworth jd. Semin Oncol. 1995 Aug;22(4 Suppl 9):75-7. Semin Oncol. 1995. PMID: 7644932 Clinical Trial.

10

The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancer.

Hainsworth JD. Hainsworth JD. Ann Oncol. 1993;4 Suppl 2:37-40. doi: 10.1093/annonc/4.suppl_2.s37. Ann Oncol. 1993. PMID: 7688982 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

480 results

Search Page